Pure Global

Unconjugated Estriol (Maglumi Unconjugated Estriol ) - India CDSCO Medical Device Registration

Unconjugated Estriol (Maglumi Unconjugated Estriol ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000124_ccdb70055b817b660be8b7475f5af163_58acfba2cf7dc1ec403f163834293cd2. This device is marketed under the brand name Maglumi Starter 1+2. The license holder is ANAND HEALTHCARE SERVICES, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Unconjugated Estriol (Maglumi Unconjugated Estriol )
UID: IMP/IVD/2023/000124_ccdb70055b817b660be8b7475f5af163_58acfba2cf7dc1ec403f163834293cd2

Brand Name

Maglumi Starter 1+2

Device Class

Class B

Approving Authority

CDSCO

Product Information

The kit is an in vitro chemiluminescence immunoassay for the quantitative determination of Unconjugated Estriol (Maglumi Starter 1+2) in human serum and plasma using the MAGLUMI series Fully-auto chemiluminescence immunoassay analyzer and Biolumi series Integrated System, and the assay is used for an aid in the assessment of abnormal pregnancies

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing